Cognitive Basic Assessment
Please log in to see the price

Please note that this product can only be administrated if you have an online VTS Standard Subscription or a local VTS version from 8.0.00 or higher.

This product requires an additional device.

Field of Application+

Detailed Description+

The COGBAT Cognitive Basic Assessment test set measures neuropsychological dimensions that are relevant to many different patient groups.
It is used to clarify the cognitive status of patients with neurological and/or psychiatric disorders. COGBAT is used with individuals with psychiatric disorders or organic diseases. However, it is also used with individuals who are undergoing treatment that might impair cognition and with individuals with post-operative cognitive dysfunction. The aim is to assess cognitive status as comprehensively (broadly) as possible but also in a manner that is as economical as possible in terms of time. Using carefully selected and in some cases specially adapted tests, the test set measures subdimensions in the areas of attention, memory and executive functions. COGBAT thus identifies cognitive areas in which a deficit may be present and follow-up assessments enable a comparison between two test sessions (e.g. when evaluating an intervention). Thus the test set is available in two parallel test forms (S1 and S2). Significant areas can then be investigated in depth with specific tests.
An easily understood evaluation provides a rapid overview of impaired and unimpaired dimensions. COGBAT is often used in situations in which for reasons of time neuropsychological testing has not in the past been carried out routinely, or when specific neuropsychological expertise is unavailable. For example, it is of use in outpatient psychotherapy practices, neurological, psychosomatic and cardiac rehabilitation centers, psychiatric clinics, day centers and hospital outpatient clinics. The focus is often on the possibility of reintegration to work.
A special feature of COGBAT is the global norming, which enables an individual’s results to be compared with those of a representative sample over all age groups (adolescence and adults).





English (USA)













The dimensions of the test set were selected in a multi-stage process. First, a shortlist of relevant cognitive dimensions was drawn up by the authors from the current literature. This shortlist was submitted to various experts for discussion and to obtain their opinion. In parallel with the selection of dimensions, a comprehensive literature search was carried out to identify up-to-date and clinically proven test paradigms. The paradigms were evaluated in terms of time efficiency, publication frequency, faithfulness to concept, experience of use with neurological and psychiatric patient groups, validity and reliability. Construct validity was evidenced through confirmatory factor analysis. Subsequent multicentric studies showed that the test, which is economical in terms of both time and resources, identifies significant differences between healthy subjects and depressive or schizophrenic individuals.

Test administration+

Controlled Mode


The COGBAT test set comprises the following dimensions and tests:
DimensionsTestsTest formsDuration in min.
Total length if all dimensions are presentedapprox. 53
Alertness, visualWAFS1approx. 2
Divided attentionWAFS1approx. 6
Processing speedTMT-LS1/ Part Aapprox. 1
Subdimension: Learning ability Subdimension: Short-term recall Subdimension: Long-term recall Subdimension: RecognitionFGTS11approx. 14
Executive functions
Cognitive flexibilityTMT-LS1/ Part Bapprox. 1
Planning abilityTOL-FS1approx. 16
Working Memory, verbalNBVS1approx. 9
Additional information
Response InhibitionINHIBS13approx. 4
The following tests can be used to test other functions if required:
DimensionsTestsTest formsDuration in min.
approx. 13
Mouse useMOUSES1approx. 2
Neglect/visual fieldWAFS1approx. 6
Subjectively experienced mental abilityFLEIS1approx. 5

  • COGBAT index: rapid assessment of general cognitive impairment across dimensions.
  • Dimension-specific indices: Dimension-specific parameter of cognitive impairment is highly relevant for differential diagnosis and/or further treatment (e.g. cognitive training).
  • Table of raw scores, percentile ranks and confidence intervals and rating of relevant dimensions using a simple color scheme (traffic-light system: red-yellow-green).
  • Profile.
  • Written report in short and long versions with profile diagram and verbal description of the individual results. Here, too, the traffic light color scheme makes it easy to take in the results at a glance.
  • Joint table showing the initial and follow-up assessment including reliable change indices (RCI) for the case-by-case statistical assessment of changes in cognitive ability

I would like: +
My data +
My Message +
Products specifications
LanguagesEnglish (USA)
Test informationcross-test norming <i class="fas fa-info-circle tooltips test-info" data-container="body" data-placement="top" data-toggle="tooltip" title="The entire test set has been administered to a representative sample. This yields cross-test norms."></i>
Test informationcross-test validation <i class="fas fa-info-circle tooltips test-info" data-container="body" data-placement="top" data-toggle="tooltip" title="The practical value of the test set has been demonstrated in at least one validation study."></i>
Test informationadditional device required <i class="fas fa-info-circle tooltips test-info" data-container="body" data-placement="top" data-toggle="tooltip" title="A SCHUHFRIED peripheral device (e.g. a Response Panel) is needed for proper administration of the test."></i>
Test informationtest(s) specifically adapted for test set <i class="fas fa-info-circle tooltips test-info" data-container="body" data-placement="top" data-toggle="tooltip" title="At least one test has been adapted for administration in the test set. For example, a specifically adapted test may have been shortened to reduce the overall testing time. The psychometric properties of all adaptations have been investigated and confirmed."></i>